A melanocytic nevus is a benign proliferation of pigment-producing cells. Most are exactly what they appear to be. The clinical problem is that appearance alone does not separate the ones that are from the ones that are not, and every method of removing a mole destroys tissue.
Key Facts
- 96.4% — clinical clearance reported for surgical excision of melanocytic nevi in a meta-analysis of 46 studies and 4,201 lesions
- 2.1% — the recurrence rate for surgical excision in the same analysis — the lowest of any modality reviewed
- 12.9% – 22.7% — recurrence reported for the non-surgical methods: CO2 laser 12.9%, Er:YAG 14.3%, electrosurgery 16.1%, dermabrasion 22.7%
- 8.8 vs 6.2 — cosmetic satisfaction out of 10 — Er:YAG laser highest, surgical excision lowest, the exact inverse of the recurrence ranking
- RR 1.82 — the increased recurrence risk for intradermal compared with junctional nevi, because depth determines what a surface-limited method can reach
- 2,940 nm vs 10,600 nm — Er:YAG versus CO2 — the shorter wavelength is absorbed more strongly by water, removing tissue with less thermal spread into surrounding skin
- 7.8% — recurrence reported for dermoscopy-guided shave removal in darker skin phenotypes, where the endpoint is judged optically rather than by eye
- Fitzpatrick III–V — the skin types in which post-inflammatory hyperpigmentation after ablative treatment is reported more frequently, which is most of the population presenting in Singapore
What the evidence actually shows
A 2026 systematic review and meta-analysis pooled 46 studies covering 4,201 lesions and compared the modalities directly. Surgical excision produced the highest clinical clearance at 96.4% and the lowest recurrence at 2.1%. The non-surgical methods clustered well behind it: CO2 laser recurred in 12.9% of cases, Er:YAG laser 14.3%, electrosurgery 16.1%, dermabrasion 22.7%.
Then the same analysis scored cosmetic outcome, and the ranking inverted. Er:YAG laser rated highest at 8.8 out of 10, CO2 laser 8.4, shave excision 7.6, surgical excision last at 6.2. That inversion is the whole decision in one line: the method that clears most reliably leaves the most visible mark, and the method that leaves the least mark clears least reliably.
A mole is not a cosmetic object until it has been examined. Vaporising a lesion removes the pigment and the evidence in the same pass — and only one of those grows back.
Why depth decides the recurrence rate
Junctional nevi sit at the dermo-epidermal junction. Intradermal nevi extend deeper. Ablative lasers vaporise tissue to a controlled depth, so nevus cells below that depth simply remain, and pigment returns as they repopulate. The meta-analysis put a number on it: recurrence in intradermal nevi ran significantly higher than in junctional nevi, with a relative risk of 1.82.
This is not a shortcoming of laser as a technology. It is a mismatch between a surface-limited method and a lesion that is not surface-limited. Establishing which one is in front of you is a clinical assessment, not a preference.
Where laser genuinely earns its place
For a suitable lesion — benign on assessment, appropriately shallow, in a site where a linear scar would be conspicuous — ablative removal is a reasonable choice, and the cosmetic satisfaction data explain why patients prefer it. We use both approaches here, and the laser arm exists because a well-selected lesion can be treated with a smaller wound and a shorter recovery than a scalpel would require.
The wavelength matters to that recovery. CO2 operates at 10,600 nm and penetrates more deeply; Er:YAG operates at 2,940 nm, where absorption by water is stronger, so tissue is removed with less heat spreading into the skin around it. Published comparisons associate the shorter wavelength with faster re-epithelialisation and less prolonged erythema, and the deeper wavelength with greater tissue effect. Neither is the better laser in the abstract. They are different instruments, and the lesion selects one.
Published work also shows the endpoint can be judged better than by eye. Dermoscopy-guided shave removal reported recurrence of 7.8% in darker skin phenotypes, and a prospective cohort using dermoscopy to guide combined CO2 and 1064 nm treatment of junctional nevi reported reduced recurrence and scar severity against unguided treatment. Looking properly at what is being removed, while removing it, changes the result.
The part that is easy to skip
Ablation leaves no specimen. If a lesion is vaporised and later proves to have been something other than a simple nevus, the tissue that would have answered the question no longer exists. There is a second-order problem too: the literature on congenital nevi notes that scarring from removal can mask a lesion developing at the same site, complicating detection afterwards.
So the sequence is fixed. Assess first — history, clinical examination, dermoscopy where indicated. If anything about the lesion warrants histopathology, it is excised and sent, and the cosmetic conversation waits. If it is straightforwardly benign, the method is then chosen on depth, site, skin type and how much downtime is acceptable.
Skin type changes the calculation
Post-inflammatory hyperpigmentation after ablative treatment is reported more frequently in Fitzpatrick III to V skin, which describes most of the population presenting in Singapore. It is usually temporary, but it means settings, depth and aftercare are adjusted for the skin in front of us rather than run to a fixed protocol — the same principle that governs pigment work generally, discussed in our melasma article and on the pico laser page.
When removal is deferred
A lesion that has changed recently in size, colour, border or symmetry, or that is bleeding, itching or newly raised, is not a cosmetic case until it has been properly evaluated. Neither is a lesion in someone with a personal or family history that raises the index of suspicion. Deferring removal in order to examine something correctly is not caution for its own sake; it is the only sequence that preserves the option of an answer.
References
- Aesthetic techniques for melanocytic nevus management: clinical outcomes, cosmetic satisfaction, and safety — a systematic review and meta-analysis. Frontiers in Medicine. 2026. Front Med 2026
- Prospective cohort study assessing the efficacy of dermoscopy-guided combination therapy using CO2 and 1064-nm lasers for junctional nevus. PubMed Central. PMC12926111
- Dermoscopic-Guided Shave Removal of Acquired Facial Melanocytic Nevi in Dark-Skinned Individuals. PubMed. 2024. PMID 38662517
- Updates in the Management of Congenital Melanocytic Nevi. PubMed Central. 2024. PMC10814732
- Xiao C, Zhang J, Peng J. Long-term efficacy and safety of carbon dioxide (CO2) array laser versus erbium-doped yttrium aluminum garnet (Er:YAG) laser. American Journal of Translational Research. 2025;17. PMC12432690
If you have a mole you would like assessed before deciding anything about removal, that is the appointment to make.
Book My AppointmentFrequently Asked Questions
Yes, and this is the step that matters most. Removal by any destructive method eliminates the tissue that would otherwise be available for histopathology. Assessment establishes whether the lesion is a straightforward benign nevus suitable for a cosmetic approach, or whether it needs excision with the specimen sent for examination.
They answer different questions. A meta-analysis of 46 studies found surgical excision had the highest clearance and lowest recurrence, while laser methods scored highest on cosmetic satisfaction. Ablative approaches reach a limited depth, so recurrence is higher, particularly for intradermal nevi. The lesion determines which trade-off is appropriate.
Because ablative lasers vaporise tissue to a limited depth and nevus cells sitting deeper in the dermis can remain. Reported recurrence is 12.9% for CO2 and 14.3% for Er:YAG, and it is significantly higher for intradermal nevi than for junctional ones.
CO2 operates at 10,600 nm and Er:YAG at 2,940 nm. The Er:YAG wavelength is absorbed more strongly by water, which limits heat spread into surrounding tissue and is associated with a faster recovery, while CO2 penetrates deeper. Neither is universally preferable; the choice follows the lesion, its depth, and the skin type.
Every method leaves something. Excision produces a linear scar and the most reliable clearance; ablative and shave methods generally produce a better cosmetic result and a higher chance of the lesion returning. There is a further consideration: scarring from removal can obscure a lesion that later needs monitoring, which is another reason assessment precedes method.